Cargando…
Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer
Breast cancer (BC) is the most diagnosed cancer worldwide, mainly affecting the epithelial cells from the mammary glands. When it expresses the estrogen receptor (ER), the tumor is called luminal BC, which is eligible for endocrine therapy with hormone signaling blockade. Hormone therapy is essentia...
Autores principales: | da Silva, Fernanda Cardoso, Brandão, Douglas Cardoso, Ferreira, Everton Allan, Siqueira, Raoni Pais, Ferreira, Helen Soares Valença, Da Silva Filho, Ademar Alves, Araújo, Thaise Gonçalves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610388/ https://www.ncbi.nlm.nih.gov/pubmed/37895937 http://dx.doi.org/10.3390/ph16101466 |
Ejemplares similares
-
Glyphosate and Aminomethylphosphonic Acid (AMPA) Modulate Glutathione S-Transferase in Non-Tumorigenic Prostate Cells
por: Borges, Dayanne Silva, et al.
Publicado: (2023) -
Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells
por: Brandão, Douglas C., et al.
Publicado: (2022) -
Annexin A1 as a Regulator of Immune Response in Cancer
por: Araújo, Thaise Gonçalves, et al.
Publicado: (2021) -
Splicing Regulators and Their Roles in Cancer Biology and Therapy
por: da Silva, Maria Roméria, et al.
Publicado: (2015) -
Endothelial dysfunction due to the inhibition of the synthesis of nitric oxide: Proposal and characterization of an in vitro cellular model
por: da Silva, Fernanda Cardoso, et al.
Publicado: (2022)